These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10335519)

  • 1. Lack of association of transforming growth factor (TGF)-beta 1 and beta 2 gene polymorphisms with multiple sclerosis (MS) in Northern Ireland.
    McDonnell GV; Kirk CW; Hawkins SA; Graham CA
    Mult Scler; 1999 Apr; 5(2):105-9. PubMed ID: 10335519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis.
    McDonnell GV; Kirk CW; Middleton D; Droogan AG; Hawkins SA; Patterson CC; Graham CA
    J Neurol; 1999 Nov; 246(11):1051-8. PubMed ID: 10631637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis.
    McDonnell GV; Mawhinney H; Graham CA; Hawkins SA; Middleton D
    J Neurol Sci; 1999 May; 165(1):77-83. PubMed ID: 10426152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis.
    McDonnell GV; Kirk CW; Hawkins SA; Graham CA
    J Neurol Sci; 2000 May; 176(1):4-12. PubMed ID: 10865086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course.
    Silversides JA; Heggarty SV; McDonnell GV; Hawkins SA; Graham CA
    Mult Scler; 2004 Apr; 10(2):149-52. PubMed ID: 15124759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.
    Booth DR; Arthur AT; Teutsch SM; Bye C; Rubio J; Armati PJ; Pollard JD; Heard RN; Stewart GJ;
    J Mol Med (Berl); 2005 Oct; 83(10):822-30. PubMed ID: 16075257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients.
    Mihailova S; Ivanova M; Mihaylova A; Quin L; Mikova O; Naumova E
    J Neuroimmunol; 2005 Nov; 168(1-2):138-43. PubMed ID: 16183136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.
    Heggarty S; Suppiah V; Silversides J; O'doherty C; Droogan A; McDonnell G; Hawkins S; Graham C; Vandenbroeck K
    J Neuroimmunol; 2007 Jul; 187(1-2):187-91. PubMed ID: 17524498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux.
    Lee-Chen GJ; Liu KP; Lai YC; Juang HS; Huang SY; Lin CY
    Kidney Int; 2004 Apr; 65(4):1467-72. PubMed ID: 15086490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.
    Söderström M; Hillert J; Link J; Navikas V; Fredrikson S; Link H
    Mult Scler; 1995 Nov; 1(3):173-80. PubMed ID: 9345450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 19 locus apolipoprotein C-II association with multiple sclerosis.
    Zouali H; Faure-Delanef L; Lucotte G
    Mult Scler; 1999 Apr; 5(2):134-6. PubMed ID: 10335523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy.
    Beránek M; Kanková K; Benes P; Izakovicová-Hollá L; Znojil V; Hájek D; Vlková E; Vácha J
    Am J Med Genet; 2002 May; 109(4):278-83. PubMed ID: 11992481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
    Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
    J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus: use of affected family-based controls.
    Hockertz MK; Paty DW; Beall SS
    Am J Hum Genet; 1998 Feb; 62(2):373-85. PubMed ID: 9463308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis.
    Goertsches R; Comabella M; Navarro A; Perkal H; Montalban X
    J Neuroimmunol; 2005 Jul; 164(1-2):140-7. PubMed ID: 15913795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Income in Multiple Sclerosis Patients with Different Disease Phenotypes.
    Kavaliunas A; Manouchehrinia A; Danylaite Karrenbauer V; Gyllensten H; Glaser A; Alexanderson K; Hillert J
    PLoS One; 2017; 12(1):e0169460. PubMed ID: 28081163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
    Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population.
    Gray OM; Abdeen H; McDonnell GV; Patterson CC; Graham CA; Hawkins SA
    Mult Scler; 2009 Mar; 15(3):299-303. PubMed ID: 19244395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.